Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Accounts Payables: 2015-2020

Historic Accounts Payables for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $5.0 million.

  • Outlook Therapeutics' Accounts Payables rose 67.66% to $5.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $5.0 million, marking a year-over-year increase of 67.66%. This contributed to the annual value of $2.3 million for FY2019, which is 36.90% down from last year.
  • According to the latest figures from Q2 2020, Outlook Therapeutics' Accounts Payables is $5.0 million, which was up 51.48% from $3.3 million recorded in Q1 2020.
  • Over the past 5 years, Outlook Therapeutics' Accounts Payables peaked at $14.4 million during Q1 2016, and registered a low of $2.3 million during Q3 2019.
  • For the 3-year period, Outlook Therapeutics' Accounts Payables averaged around $3.7 million, with its median value being $3.5 million (2018).
  • Its Accounts Payables has fluctuated over the past 5 years, first spiked by 160.06% in 2017, then slumped by 71.58% in 2018.
  • Outlook Therapeutics' Accounts Payables (Quarterly) stood at $11.0 million in 2016, then plummeted by 67.15% to $3.6 million in 2017, then increased by 29.38% to $4.7 million in 2018, then tumbled by 45.32% to $2.6 million in 2019, then soared by 67.66% to $5.0 million in 2020.
  • Its Accounts Payables stands at $5.0 million for Q2 2020, versus $3.3 million for Q1 2020 and $2.6 million for Q4 2019.